Partners' Directory

  Home   Search   Join the Partnership   Login

Contact General Specializations in Countries Contribution to the Global Plan Declaration

View this partner's profile

Organization Contact Information

Name: BD India Pvt Ltd
Street 1: 5th and 6th Floor, Signature Towers,
Street 2: Tower B, South City I
City: Gurgaon
Province:
Post Code: 122001
Country: India
Phone: +91 124 3949390
Email: sanjay_sarin@bd.com
Web Site: http://www.bd.com

Focal Point Contact Information

Salutation: Dr
First Name: Sanjay
Last Name: Sarin
Title: Regional Director
Email: sanjay_sarin@bd.com
Phone: +91 9899961115

Alternate Focal Point Contact Information

Salutation: Mr
First Name: Punit
Last Name: Kohli
Title: Business Director
Email: punit_kohli@bd.com
Phone:  

General Information

Board Constituency: Private sector
Organization Type - Primary: Private Sector
Organization Type - Secondary: Company
Is your organization legally registered in your country: Yes
Organization Reach: International
Organization Description:
BD is a leading global medical technology company dedicated to improving people's health throughout the world. BD is focused on improving drug delivery, enhancing the quality and speed of diagnosing infectious diseases and cancers, and advancing research, discovery and production of new drugs and vaccines. BD's capabilities are instrumental in combating many of the world's most pressing diseases. The Company serves healthcare institutions, life
science researchers, clinical laboratories, the pharmaceutical industry and the general public.
 
Total number of staff in your organization: 100 +
Number of full-time staff who are directly involved with TB: 6 - 10
Number of part-time staff who are directly involved with TB: 1 - 5
Number of volunteers who are directly involved with TB: 1 - 5
 
What is your organization's annual budget (USD) dedicated to TB? $10,001-$25,000
How did you hear about the Stop TB Partnership: Stop TB communications
If you were informed or referred by another partner of the Stop TB Partnership please tell us who:
Why do you wish join the Stop TB Partnership: Involvement in Stop TB Working Groups
 
Are you a member of a Stop TB national partnership: India
Are you in contact with your national TB programme: Yes
Please tell us how your organization is contributing to your country's national TB control plan:
BD is engaged with the civil society and the National TB control program by helping improve access to improved TB diagnostics and contributing towards improving patient outcomes
 

Geographical Reach

Which country is your headquarters located in: United States of America
Which WHO region is the main focus of your work: South East Asian
Which countries do you do operate in:
(This includes countries you are conducting activities in)
Bangladesh
Bhutan
Cambodia
China
Democratic People's Republic of Korea
India
Indonesia
Myanmar
Nepal
Sri Lanka
Thailand
Viet Nam

Specializations

Provision of drugs, diagnostics and commodities

Specializations in Countries

Provision of drugs, diagnostics and commodities Bangladesh
Provision of drugs, diagnostics and commodities Bhutan
Provision of drugs, diagnostics and commodities Cambodia
Provision of drugs, diagnostics and commodities China
Provision of drugs, diagnostics and commodities Democratic People's Republic of Korea
Provision of drugs, diagnostics and commodities India
Provision of drugs, diagnostics and commodities Indonesia
Provision of drugs, diagnostics and commodities Myanmar
Provision of drugs, diagnostics and commodities Nepal
Provision of drugs, diagnostics and commodities Sri Lanka
Provision of drugs, diagnostics and commodities Thailand
Provision of drugs, diagnostics and commodities Viet Nam

Contribution

Please tell us how your organization will contribute to the Global Plan to Stop TB by briefly describing its involvement in any of the areas of work listed below:

Laboratory Strengthening:
BD is working with country TB programs and internationla gencies such as FIND, USAID, IUATLD etc. on activities related to the development for capability to diagnose MDR-TB, gthening of lab insfreatructrure, biosafety accreditation and improvement of specimen referral mechanisms

New Diagnostics:
BD is working with range of stakeholders on the introduction of liquid culture technology to improve the state of TB diagnosis in the high burden countries of SEAR

Declaration

Declaration of interests:
No conflicts of interest were delacred.

Application date: January 14, 2014
Last updated: February 18, 2014